Lothar H. Wieler | |
|---|---|
 | |
| Born | Lothar Heinz Wieler 8 February 1961 |
| Nationality | German |
| Scientific career | |
| Fields | |
| Website | www |
Lothar Heinz Wieler (born 8 February 1961) is a German veterinarian and microbiologist who served as president of the Robert Koch Institute (RKI) from 2015 to 2023.[1] In this capacity, he advised the German Federal and State Governments on topics of public health, especially infection hazards, and on the containment of the COVID-19 pandemic.[2]
Early life and education
Wieler was born in Königswinter, Germany. He studied veterinary medicine at Free University of Berlin and Ludwig Maximilian University of Munich from 1980 to 1985.[3]
Career
From 1998 until 2015, Wieler worked as professor and director of the Institute of Microbiology and Epizootics at the Free University of Berlin. During that time, he spent a sabbatical at the Wellcome Sanger Institute in Hinxton under the supervision of Gordon Dougan.[3]
Early in the COVID-19 pandemic in Germany, Wieler launched Europe’s first large-scale SARS-CoV-2 antibody testing in an effort to help researchers assess infection rates and monitor the spread of the virus more effectively; the study was carried out jointly by the Robert Koch Institute, Charité and the Helmholtz Centre for Infection Research.[4]
In addition to his role at RKI, Wieler was a member of the World Health Organization's Strategic and Technical Advisory Group for Infectious Hazards (STAG-IH) since 2018.[5] In 2020, he chaired the WHO's Committee for the Review of the International Health Regulations.[6] Also in 2020, he was appointed to the Global Leaders Group on Antimicrobial Resistance, co-chaired by Sheikh Hasina and Mia Mottley.[7]
Since 2023, Wieler has been working at the Hasso Plattner Institute.[8]
Other activities
- Virchow Prize for Global Health, Member of the Council (since 2022)[9]
- World Health Organization (WHO), Member of the European Advisory Committee on Health Research (since 2018)[10]
- Global Research Collaboration for Infectious Disease Preparedness (GloPID-R), Member of the Scientific Advisory Board (since 2016)
- Fraunhofer Institute for Telecommunications, Member of the Board of Trustees[11]
- Robert Koch Foundation, Member of the Scientific Advisory Council[12]
References
- ↑ "RKI – President – Prof. Dr. Lothar H. Wieler". www.rki.de.
- ↑ "RKI – Mission Statement". www.rki.de.
- 1 2 CV of Lothar Wieler Robert Koch Institute.
- ↑ Guy Chazan and Donato Paolo Mancini (9 April 2020), Germany to run Europe’s first large-scale antibody test programme Financial Times.
- ↑ Strategic and Technical Advisory Group for Infectious Hazards (STAG-IH) World Health Organization.
- ↑ Sheri Fink (12 May 2021), Experts Call for Sweeping Reforms to Prevent the Next Pandemic New York Times.
- ↑ Global Leaders Group on Antimicrobial Resistance World Health Organization.
- ↑ Sandra Calvez (15 June 2023), Prävention durch Digitalisierung: Was Lothar Wieler am HPI in Potsdam erreichen will Der Tagesspiegel.
- ↑ Council Virchow Prize for Global Health.
- ↑ European Advisory Committee on Health Research (EACHR) World Health Organization (WHO).
- ↑ Board of Trustees Fraunhofer Institute for Telecommunications.
- ↑ Scientific Advisory Council Robert Koch Foundation.